PFANSTIEL STEVEN (CFO) received a stock award from MARINUS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/19/2024ACC: 0001415889-24-001591
Officer· CFO
Since Apr 2021
+140.06K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
140.06K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25.46K
Price / share
—
Trade value
—
% of position
51.6%
1/18/2024
49.32K→74.79K
Total
Net shares
+25.46K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/18/2024 | A · Award | +25.46K | — | — | 51.6% | 49.32K | 74.79K |
| Total | +25.46K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
114.60K shares
Shares
+114.60K
Strike price
9.74
Held after
114.60K
Exercisable
—
1/18/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock114.60K shares | 1/18/2024 | A · Award | +114.60K | 9.74 | — | 114.60K |